 Connection
Adnin Zaman to Obesity
This is a "connection" page, showing publications Adnin Zaman has written about Obesity.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.377 |
|
|
|
-
Catenacci VA, Ostendorf DM, Pan Z, Kaizer LK, Creasy SA, Zaman A, Caldwell AE, Dahle J, Swanson B, Breit MJ, Bing K, Wayland LT, Panter SL, Scorsone JJ, Bessesen DH, MacLean P, Melanson EL. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial. Ann Intern Med. 2025 05; 178(5):634-644.
Score: 0.085
-
Thomas EA, Zaman A, Sloggett KJ, Steinke S, Grau L, Catenacci VA, Cornier MA, Rynders CA. Early time-restricted eating compared with daily caloric restriction: A randomized trial in adults with obesity. Obesity (Silver Spring). 2022 05; 30(5):1027-1038.
Score: 0.069
-
Zaman A, Sloggett KJ, Caldwell AE, Catenacci VA, Cornier MA, Grau L, Vetter C, Rynders CA, Thomas EA. The effects of the COVID-19 pandemic on weight loss in participants in a behavioral weight-loss intervention. Obesity (Silver Spring). 2022 05; 30(5):1015-1026.
Score: 0.069
-
Siebert JC, Stanislawski MA, Zaman A, Ostendorf DM, Konigsberg IR, Jambal P, Ir D, Bing K, Wayland L, Scorsone JJ, Lozupone CA, Görg C, Frank DN, Bessesen D, MacLean PS, Melanson EL, Catenacci VA, Borengasser SJ. Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention. Obesity (Silver Spring). 2021 05; 29(5):859-869.
Score: 0.064
-
Yu Y, Li X, Groth SW, Zaman A, Chao AM, Phelan S, Hollenbach SJ, Dreisbach C. Gestational Weight Gain and Pregnancy Outcomes After Semaglutide Exposure. Obstet Gynecol. 2026 Aug 01; 148(2):229-237.
Score: 0.023
-
Ostendorf DM, Caldwell AE, Zaman A, Pan Z, Bing K, Wayland LT, Creasy SA, Bessesen DH, MacLean P, Melanson EL, Catenacci VA. Comparison of weight loss induced by daily caloric restriction versus intermittent fasting (DRIFT) in individuals with obesity: study protocol for a 52-week randomized clinical trial. Trials. 2022 Aug 29; 23(1):718.
Score: 0.018
-
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610.
Score: 0.018
-
Iwamoto SJ, Abushamat LA, Zaman A, Millard AJ, Cornier MA. Obesity Management in Cardiometabolic Disease: State of the Art. Curr Atheroscler Rep. 2021 08 04; 23(10):59.
Score: 0.016
-
Thomas EA, Zaman A, Cornier MA, Catenacci VA, Tussey EJ, Grau L, Arbet J, Broussard JL, Rynders CA. Later Meal and Sleep Timing Predicts Higher Percent Body Fat. Nutrients. 2020 Dec 29; 13(1).
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|